Real-World Harm Reduction of Metformin Plus DPP4 Inhibitors versus Metformin Plus Sulfonylureas in Older Adults: A Target Trial Emulation Using German Claims Data.
Saved in:
| Title: | Real-World Harm Reduction of Metformin Plus DPP4 Inhibitors versus Metformin Plus Sulfonylureas in Older Adults: A Target Trial Emulation Using German Claims Data. |
|---|---|
| Authors: | Starke P; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany. paula.starke@med.uni-goettingen.de., Thürmann P; Clinical Pharmacology, Faculty of Health, University of Witten/Herdecke, Witten, Germany., Grobe T; aQua-Institut GmbH, Göttingen, Germany., Friede T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany., Mathes T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany. |
| Source: | Drugs & aging [Drugs Aging] 2025 Jul; Vol. 42 (7), pp. 655-663. Date of Electronic Publication: 2025 Jun 10. |
| Publication Type: | Journal Article; Comparative Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1969 (Electronic) Linking ISSN: 1170229X NLM ISO Abbreviation: Drugs Aging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1969 |
|---|---|
| DOI: | 10.1007/s40266-025-01218-0 |
